Evogen Study at 2017 AES Annual Meeting Identifies New Proteomic Biomarkers for Diagnosis of Epileptic Seizures

December 2, 2017

Responsive image

PHILADELPHIA and WASHINGTON, Dec. 2, 2017 /PRNewswire/ — Evogen, Inc., a leader in proteomics and genomics-based testing for improved diagnosis and treatment of neurological disorders, today reported that a clinical study to be presented at the 2017 Annual Meeting of the American…

Category: Precious Metals